Analysis and Commentary STEVEN GROSSMAN 11/7/14 Analysis and Commentary STEVEN GROSSMAN 11/7/14 Change Is Unsettling ... But Our Message Remains the Same Read More Advocacy at a Glance STEVEN GROSSMAN 11/7/14 Advocacy at a Glance STEVEN GROSSMAN 11/7/14 Election Results: New Republican Senate Majority, Expanded Republican House Majority and more Read More Advocacy at a Glance STEVEN GROSSMAN 10/31/14 Advocacy at a Glance STEVEN GROSSMAN 10/31/14 Ebola: FDA On the Job and more Read More Analysis and Commentary STEVEN GROSSMAN 10/31/14 Analysis and Commentary STEVEN GROSSMAN 10/31/14 Planning for a Late Night Watching "the Box" Read More Analysis and Commentary STEVEN GROSSMAN 10/24/14 Analysis and Commentary STEVEN GROSSMAN 10/24/14 FDA Can't Just Pare Back Without Risk for Harm Read More Advocacy at a Glance STEVEN GROSSMAN 10/24/14 Advocacy at a Glance STEVEN GROSSMAN 10/24/14 FDA Approves 34 NME Drugs So Far in 2014 and more Read More Analysis and Commentary STEVEN GROSSMAN 10/18/14 Analysis and Commentary STEVEN GROSSMAN 10/18/14 Appropriators Are the First Priority, But ... Read More Advocacy at a Glance STEVEN GROSSMAN 10/18/14 Advocacy at a Glance STEVEN GROSSMAN 10/18/14 Alliance Holds “FDA 101” Hill Briefing and more Read More Analysis and Commentary STEVEN GROSSMAN 10/10/14 Analysis and Commentary STEVEN GROSSMAN 10/10/14 When Tough Choices Get Made, FDA Will Prevail Read More Advocacy at a Glance STEVEN GROSSMAN 10/10/14 Advocacy at a Glance STEVEN GROSSMAN 10/10/14 Alliance Launches Planned Series of Hill “FDA 101” Briefings and more Read More Uncategorized STEVEN GROSSMAN 10/9/14 Uncategorized STEVEN GROSSMAN 10/9/14 Alliance to Hold Congressional Staff Briefing Read More Analysis and Commentary STEVEN GROSSMAN 10/3/14 Analysis and Commentary STEVEN GROSSMAN 10/3/14 Good ... But Not Good Enough! Read More Advocacy at a Glance STEVEN GROSSMAN 10/3/14 Advocacy at a Glance STEVEN GROSSMAN 10/3/14 Quiet Start to Fiscal Year 2015 and more Read More Analysis and Commentary STEVEN GROSSMAN 9/26/14 Analysis and Commentary STEVEN GROSSMAN 9/26/14 An X-Like Prize for Regulatory Science Read More Advocacy at a Glance STEVEN GROSSMAN 9/26/14 Advocacy at a Glance STEVEN GROSSMAN 9/26/14 FY 15 Continuing Resolution to Go into Effect October 1 and more Read More Membership Matters STEVEN GROSSMAN 9/24/14 Membership Matters STEVEN GROSSMAN 9/24/14 Alliance to Hold Webinar on Outlook for Mid-term Elections Read More Analysis and Commentary STEVEN GROSSMAN 9/19/14 Analysis and Commentary STEVEN GROSSMAN 9/19/14 What May the Road Look Like Come November? Read More Advocacy at a Glance STEVEN GROSSMAN 9/19/14 Advocacy at a Glance STEVEN GROSSMAN 9/19/14 FDA Under the Continuing Resolution: The Good and The Bad and more Read More Analysis and Commentary STEVEN GROSSMAN 9/12/14 Analysis and Commentary STEVEN GROSSMAN 9/12/14 Agency Growth ... And Macro-Budgetary Politics Read More Advocacy at a Glance STEVEN GROSSMAN 9/12/14 Advocacy at a Glance STEVEN GROSSMAN 9/12/14 CR Anomalies and more Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 11/7/14 Analysis and Commentary STEVEN GROSSMAN 11/7/14 Change Is Unsettling ... But Our Message Remains the Same Read More
Advocacy at a Glance STEVEN GROSSMAN 11/7/14 Advocacy at a Glance STEVEN GROSSMAN 11/7/14 Election Results: New Republican Senate Majority, Expanded Republican House Majority and more Read More
Advocacy at a Glance STEVEN GROSSMAN 10/31/14 Advocacy at a Glance STEVEN GROSSMAN 10/31/14 Ebola: FDA On the Job and more Read More
Analysis and Commentary STEVEN GROSSMAN 10/31/14 Analysis and Commentary STEVEN GROSSMAN 10/31/14 Planning for a Late Night Watching "the Box" Read More
Analysis and Commentary STEVEN GROSSMAN 10/24/14 Analysis and Commentary STEVEN GROSSMAN 10/24/14 FDA Can't Just Pare Back Without Risk for Harm Read More
Advocacy at a Glance STEVEN GROSSMAN 10/24/14 Advocacy at a Glance STEVEN GROSSMAN 10/24/14 FDA Approves 34 NME Drugs So Far in 2014 and more Read More
Analysis and Commentary STEVEN GROSSMAN 10/18/14 Analysis and Commentary STEVEN GROSSMAN 10/18/14 Appropriators Are the First Priority, But ... Read More
Advocacy at a Glance STEVEN GROSSMAN 10/18/14 Advocacy at a Glance STEVEN GROSSMAN 10/18/14 Alliance Holds “FDA 101” Hill Briefing and more Read More
Analysis and Commentary STEVEN GROSSMAN 10/10/14 Analysis and Commentary STEVEN GROSSMAN 10/10/14 When Tough Choices Get Made, FDA Will Prevail Read More
Advocacy at a Glance STEVEN GROSSMAN 10/10/14 Advocacy at a Glance STEVEN GROSSMAN 10/10/14 Alliance Launches Planned Series of Hill “FDA 101” Briefings and more Read More
Uncategorized STEVEN GROSSMAN 10/9/14 Uncategorized STEVEN GROSSMAN 10/9/14 Alliance to Hold Congressional Staff Briefing Read More
Analysis and Commentary STEVEN GROSSMAN 10/3/14 Analysis and Commentary STEVEN GROSSMAN 10/3/14 Good ... But Not Good Enough! Read More
Advocacy at a Glance STEVEN GROSSMAN 10/3/14 Advocacy at a Glance STEVEN GROSSMAN 10/3/14 Quiet Start to Fiscal Year 2015 and more Read More
Analysis and Commentary STEVEN GROSSMAN 9/26/14 Analysis and Commentary STEVEN GROSSMAN 9/26/14 An X-Like Prize for Regulatory Science Read More
Advocacy at a Glance STEVEN GROSSMAN 9/26/14 Advocacy at a Glance STEVEN GROSSMAN 9/26/14 FY 15 Continuing Resolution to Go into Effect October 1 and more Read More
Membership Matters STEVEN GROSSMAN 9/24/14 Membership Matters STEVEN GROSSMAN 9/24/14 Alliance to Hold Webinar on Outlook for Mid-term Elections Read More
Analysis and Commentary STEVEN GROSSMAN 9/19/14 Analysis and Commentary STEVEN GROSSMAN 9/19/14 What May the Road Look Like Come November? Read More
Advocacy at a Glance STEVEN GROSSMAN 9/19/14 Advocacy at a Glance STEVEN GROSSMAN 9/19/14 FDA Under the Continuing Resolution: The Good and The Bad and more Read More
Analysis and Commentary STEVEN GROSSMAN 9/12/14 Analysis and Commentary STEVEN GROSSMAN 9/12/14 Agency Growth ... And Macro-Budgetary Politics Read More
Advocacy at a Glance STEVEN GROSSMAN 9/12/14 Advocacy at a Glance STEVEN GROSSMAN 9/12/14 CR Anomalies and more Read More
